DK0501678T3 - Behandling af okulær hypertension med en synergistisk kombination - Google Patents

Behandling af okulær hypertension med en synergistisk kombination

Info

Publication number
DK0501678T3
DK0501678T3 DK92301412.0T DK92301412T DK0501678T3 DK 0501678 T3 DK0501678 T3 DK 0501678T3 DK 92301412 T DK92301412 T DK 92301412T DK 0501678 T3 DK0501678 T3 DK 0501678T3
Authority
DK
Denmark
Prior art keywords
treatment
ocular hypertension
synergistic combination
pharmaceutically acceptable
ketoprostaglandin
Prior art date
Application number
DK92301412.0T
Other languages
Danish (da)
English (en)
Inventor
Ryuji Ueno
Original Assignee
R Tech Ueno Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by R Tech Ueno Ltd filed Critical R Tech Ueno Ltd
Application granted granted Critical
Publication of DK0501678T3 publication Critical patent/DK0501678T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK92301412.0T 1991-03-01 1992-02-20 Behandling af okulær hypertension med en synergistisk kombination DK0501678T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP6132891 1991-03-01

Publications (1)

Publication Number Publication Date
DK0501678T3 true DK0501678T3 (da) 1996-05-28

Family

ID=13167964

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92301412.0T DK0501678T3 (da) 1991-03-01 1992-02-20 Behandling af okulær hypertension med en synergistisk kombination

Country Status (11)

Country Link
US (1) US5547968A (fr)
EP (1) EP0501678B1 (fr)
JP (1) JP2511611B2 (fr)
KR (1) KR100221369B1 (fr)
AT (1) ATE137407T1 (fr)
CA (1) CA2061907C (fr)
DE (1) DE69210286T2 (fr)
DK (1) DK0501678T3 (fr)
ES (1) ES2089387T3 (fr)
GR (1) GR3019820T3 (fr)
TW (1) TW210287B (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0948333A1 (fr) * 1996-11-01 1999-10-13 Alcon Laboratories, Inc. Utilisation d'une combinaison d'inhibiteurs d'anhydrase carbonique et de prostaglandines dans le traitement du glaucome
US6214381B1 (en) 1998-09-08 2001-04-10 Effcon, Inc. Methazolamide composition and method of use
US7128903B2 (en) * 2001-10-03 2006-10-31 Innovative Pharmaceutical Concepts (Ipc) Inc. Pharmaceutical preparations useful for treating tumors and lesions of the skin and the mucous membranes and methods and kits using same
US20040225014A1 (en) * 2003-02-14 2004-11-11 Sucampo Ag Method for treating ocular hypertension and glaucoma
TWI348386B (en) * 2003-08-12 2011-09-11 R Tech Ueno Ltd Composition and method for promoting hair growth
KR102074020B1 (ko) * 2012-07-13 2020-02-05 산텐 세이야꾸 가부시키가이샤 술폰아미드 화합물의 조합
US9980946B1 (en) 2017-01-25 2018-05-29 Effcon Laboratories, Inc. Extended release methazolamide formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3785602T2 (de) * 1986-03-13 1993-09-02 Univ Columbia Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
ATE76750T1 (de) * 1987-04-03 1992-06-15 Univ Columbia Anwendung eines prostaglandins in mischung mit einem adrenergischen blocker zur verminderung des augen-innendruckes.
JPH0739343B2 (ja) * 1988-10-01 1995-05-01 株式会社アールテック・ウエノ 眼圧降下剤
ES2052735T3 (es) * 1987-09-18 1994-07-16 R Tech Ueno Ltd Un metodo para producir un agente hipotensor ocular.
EP0366279B1 (fr) * 1988-10-01 1994-09-21 R-Tech Ueno Ltd. Agents oculaires hypotenseurs

Also Published As

Publication number Publication date
CA2061907A1 (fr) 1992-09-02
KR920017654A (ko) 1992-10-21
DE69210286D1 (de) 1996-06-05
GR3019820T3 (en) 1996-08-31
TW210287B (fr) 1993-08-01
ES2089387T3 (es) 1996-10-01
EP0501678B1 (fr) 1996-05-01
CA2061907C (fr) 2003-04-08
DE69210286T2 (de) 1996-09-12
JP2511611B2 (ja) 1996-07-03
ATE137407T1 (de) 1996-05-15
JPH0565227A (ja) 1993-03-19
EP0501678A3 (en) 1992-12-16
EP0501678A2 (fr) 1992-09-02
US5547968A (en) 1996-08-20
KR100221369B1 (ko) 1999-09-15

Similar Documents

Publication Publication Date Title
AR013742A1 (es) Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida
MX9204381A (es) Metodo para tratar inflamacion ocular
DE69212203D1 (de) Intrakorporale injizierbare Zusammensetzung zum Implantieren von hochkonzentriertem vernetzten Atelokollagen
DK0867184T3 (da) Anvendelse af tiagabin til behandling af søvnforstyrrelser
DK0652005T3 (da) Fremgangsmåder til inhibering af endometriose
DK0432117T3 (da) Farmaceutisk præparat til behandling af inflammation
DK0459666T3 (da) Lægemidler mod impotens
ES2071227T3 (es) Composicion para gotas para los ojos.
DK0651999T3 (da) Fremgangsmåder til inhibering af livmoderfibrose
DK0501678T3 (da) Behandling af okulær hypertension med en synergistisk kombination
DK0458588T3 (da) Behandling af okulær hypertension med en synergistisk kombination til okulær administration
EA199900431A1 (ru) Способ профилактики рака молочной железы
DK0498144T3 (da) Anvendelse af acetyl-L-carnitin ved terapeutisk behandling af coma
DK0901790T3 (da) Anvendelse af moxonidin til behandling af neuropatisk smerte
DK0662325T3 (da) Inhibering af ovariedysgenese, forsinket pubertet eller sexuel infantilisme
DK0458589T3 (da) Behandling af okulær hypertension med en okulær synergistisk kombination
DK0458590T3 (da) Behandling af okulær hypertension med en synergistisk konbination
DK0458587T3 (da) Behandling af okulær hypertension med en synergistisk kombination til ophthalmisk anvendelse
ATE133337T1 (de) Behandlung des glaukoms mit synergistischer kombination
ATE82850T1 (de) Verwendung von 2-pyrimidinyl-1-piperazinderivaten.
DK0791355T3 (da) Fremgangsmåde til reduktion af vævsbeskadigelse forbundet med iskæmi
ES2129401T3 (es) Uso de un compuesto terapeutico para el tratamiento de bronquitis.
DK0711163T3 (da) Anvendelse af benzydamin i behandlingen af patologiske tilstande forårsaget af TNF
ATE232724T1 (de) Inhibitor von stickstoffmonoxid (no) synthase zur verhütung von typ ii diabetes
DK0728002T3 (da) Anvendelse af 2-aminopurinderivater til behandling og forebyggelse af humant herpesvirus 7-infektioner